MIP-1095 I-123

DB12994ExperimentalSmall molecule

123 I Mip 1095 is under investigation in clinical trial NCT00712829 (Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents).

Formula / weight: C₁₉H₂₅IN₄O₈ · 560.335 g/mol (avg)
Code names: MIP-1095 I-123

Resolves to

Compound

UNIIHD4940602JCAS949575-25-1ChEMBLCHEMBL498623PubChem25168442

Structure

InChIKeyLFEGKCKGGNXWDV-NKNRFTOXSA-NSMILESOC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)NC1=CC=C([123I])C=C1)C(O)=O)C(O)=O

Which companies are running trials of MIP-1095 I-123, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account